Google
IQV 株価分析 — IQVIA HOLDINGS INC (Healthcare >> Diagnostics & Research)
IQV に関するよくある質問
IQVのPER（株価収益率）は？
IQVIA HOLDINGS INC（IQV）は現在PER 28.06倍で取引されています。
IQVのROE（自己資本利益率）は？
IQVIA HOLDINGS INCのROEは22.28%です。
IQVの配当利回りは？
IQVIA HOLDINGS INCの配当利回りは0.00%です。
IQVの品質スコア（Quality Score）は？
当社のAIはIQVの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
IQVは今が買い時ですか？
当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
IQVはどのセクターに属しますか？
IQVIA HOLDINGS INCはHealthcare >> Diagnostics & Researchセクターに分類されます（NYSE市場）
IQV AI Analysis Summary
Our AI summary for IQV: IQVIA HOLDINGS INC (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 28.06, ROE of 22.28%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 235.02
Price
-2.77
(-1.16%)
Day Change
|
|
|---|
IQV, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1989
|
| Magic Formula Rank by ROE |
1989
|
| Magic Formula Rank by ROIC |
2122
|
| Price | 235.02 |
| PBV / Sector |
6.12 / -29.69
|
| Earning Per Share | 8.38 |
| PE / Sector |
28.06 / 48.18
|
| PEG or PE/Growth / Sector |
N/A / 1.64
|
| Average 1M Daily Value |
275.35 M
GREAT
|
| Average 1W Daily Value |
529.15 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:02 |
| Symbol | IQV |
| Name | IQVIA HOLDINGS INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NYSE |
| Listed Shares | 164.60 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 38,581.42 / 38,081.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2400 Ellis Road, Durham, NC, United States, 27703
Phone: 919 998 2000
Website: https://www.iqvia.com
Employees: 93,000
Description: IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
